Cargando…

The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system

The NovoTTF™-100A system is a portable device that delivers intermediate frequency alternating electric fields (TTFields, tumor treating fields) through transducer arrays arranged on the scalp. An ongoing trial is assessing its efficacy for newly diagnosed glioblastoma multiforme (GBM) and it has be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turner, Scott G, Gergel, Thomas, Wu, Hueizhi, Lacroix, Michel, Toms, Steven A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036833/ https://www.ncbi.nlm.nih.gov/pubmed/24884522 http://dx.doi.org/10.1186/1477-7819-12-162

Ejemplares similares

Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma
por: Wong, Eric T, et al.
Publicado: (2014)

NovoTTF(™)-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL(™) system user study
por: Chaudhry, Aafia, et al.
Publicado: (2015)

An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
por: Swanson, Kenneth D., et al.
Publicado: (2016)

Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation
por: Wong, Eric T, et al.
Publicado: (2015)

PEDT-9 A study of NovoTTF-100A to expand the regulatory indication for childhood glioblastoma through a pediatric clinical trial based on the Advanced Medical Care system
por: Yuza, Yuki, et al.
Publicado: (2021)

COT-23 INITIAL EXPERIENCE OF TREATMENT FOR GLIOBLASTOMA BY NOVO-TTF
por: Omura, Takaki, et al.
Publicado: (2019)

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
por: Fabian, Denise, et al.
Publicado: (2019)

Safety and efficacy of tumour-treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
por: Nishikawa, Ryo, et al.
Publicado: (2023)

ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION
por: Yamaguchi, Shigeru, et al.
Publicado: (2019)

Correction to: Safety and efficacy of Tumor Treating fields (TTFields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-TTF System: a prospective post-approval study
Publicado: (2023)

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
por: Rulseh, Aaron Michael, et al.
Publicado: (2012)

COT-19 TREATMENT EXPERIENCE OF AND TIPS FOR ADMINISTRATING NOVO TTF
por: Shimada, Daisuke, et al.
Publicado: (2019)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013)

The role of metabolic therapy in treating glioblastoma multiforme
por: Maroon, Joseph C., et al.
Publicado: (2015)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

HGG-10. A SAFETY AND EFFICACY STUDY OF NOVOTTF-100A FOR PEDIATRIC HIGH-GRADE GLIOMA: RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE FIRST THREE CASES
por: Makimoto, Atsushi, et al.
Publicado: (2023)

Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
por: Heynckes, Sabrina, et al.
Publicado: (2017)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

OptimalTTF-1: Enhancing tumor treating fields therapy with skull remodeling surgery. A clinical phase I trial in adult recurrent glioblastoma
por: Korshoej, Anders Rosendal, et al.
Publicado: (2020)

TTF Meeting
por: Edwards, D A
Publicado: (1997)

SAT1 and glioblastoma multiforme: Disarming the resistance
por: Brett-Morris, Adina, et al.
Publicado: (2015)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Wake Field Calculation for the TTF-FEL Bunch Compressor Section
por: Rothemund, K, et al.
Publicado: (1999)

Glioblastoma Multiforme—Treating a Deadly Tumor with Both Strands of RNA
por: Weil, Robert J
Publicado: (2006)

Minocycline in Treating Glioblastoma Multiforme: Far beyond a Conventional Antibiotic
por: Afshari, Amir R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_msd2o72f7ng685iavnoaqivfb1